212 related articles for article (PubMed ID: 21849352)
1. Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes.
Zaruba MM; Zhu W; Soonpaa MH; Reuter S; Franz WM; Field LJ
Eur Heart J; 2012 Jan; 33(1):129-37. PubMed ID: 21849352
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.
Hassink RJ; Pasumarthi KB; Nakajima H; Rubart M; Soonpaa MH; de la Rivière AB; Doevendans PA; Field LJ
Cardiovasc Res; 2008 Apr; 78(1):18-25. PubMed ID: 18079102
[TBL] [Abstract][Full Text] [Related]
3. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.
Zaruba MM; Theiss HD; Vallaster M; Mehl U; Brunner S; David R; Fischer R; Krieg L; Hirsch E; Huber B; Nathan P; Israel L; Imhof A; Herbach N; Assmann G; Wanke R; Mueller-Hoecker J; Steinbeck G; Franz WM
Cell Stem Cell; 2009 Apr; 4(4):313-23. PubMed ID: 19341621
[TBL] [Abstract][Full Text] [Related]
4. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
[TBL] [Abstract][Full Text] [Related]
5. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
[TBL] [Abstract][Full Text] [Related]
6. Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart.
Eghbali A; Dukes A; Toischer K; Hasenfuss G; Field LJ
Curr Cardiol Rep; 2019 Sep; 21(10):131. PubMed ID: 31529165
[TBL] [Abstract][Full Text] [Related]
7. Effect of a long-term treatment with a low-dose granulocyte colony-stimulating factor on post-infarction process in the heart.
Okada H; Takemura G; Li Y; Ohno T; Li L; Maruyama R; Esaki M; Miyata S; Kanamori H; Ogino A; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Cell Mol Med; 2008 Aug; 12(4):1272-83. PubMed ID: 18298650
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
[TBL] [Abstract][Full Text] [Related]
9. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.
Lehrke S; Mazhari R; Durand DJ; Zheng M; Bedja D; Zimmet JM; Schuleri KH; Chi AS; Gabrielson KL; Hare JM
Circ Res; 2006 Sep; 99(5):553-60. PubMed ID: 16873716
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.
Theiss HD; Gross L; Vallaster M; David R; Brunner S; Brenner C; Nathan P; Assmann G; Mueller-Hoecker J; Vogeser M; Steinbeck G; Franz WM
Int J Cardiol; 2013 Oct; 168(4):3359-69. PubMed ID: 23669105
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction.
Cheng Z; Liu X; Ou L; Zhou X; Liu Y; Jia X; Zhang J; Li Y; Kong D
Cardiovasc Drugs Ther; 2008 Oct; 22(5):363-71. PubMed ID: 18461431
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.
Gross L; Paintmayer L; Lehner S; Brandl L; Brenner C; Grabmaier U; Huber B; Bartenstein P; Theiss HD; Franz WM; Massberg S; Todica A; Brunner S
Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):136-45. PubMed ID: 26420287
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor increases sympathetic reinnervation and the arrhythmogenic response to programmed electrical stimulation after myocardial infarction in rats.
Lee TM; Chen CC; Chang NC
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H512-22. PubMed ID: 19502563
[TBL] [Abstract][Full Text] [Related]
16. [Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction].
Kuethe F; Figulla HR; Voth M; Richartz BM; Opfermann T; Sayer HG; Krack A; Fritzenwanger M; Höffken K; Gottschild D; Werner GS
Dtsch Med Wochenschr; 2004 Feb; 129(9):424-8. PubMed ID: 14970913
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP
Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464
[TBL] [Abstract][Full Text] [Related]
18. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
Delgaudine M; Gothot A; Beguin Y
Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
